High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer

被引:65
作者
Stange, DE
Radlwimmer, B
Schubert, F
Traub, F
Pich, A
Toedt, G
Mendrzyk, F
Lehmann, U
Eils, R
Kreipe, H
Lichter, P
机构
[1] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany
[3] Hannover Med Sch, Inst Pathol, Hannover, Germany
关键词
D O I
10.1158/1078-0432.CCR-05-1633
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Invasive ductal carcinoma and invasive lobular carcinoma (ILC) represent the major histologic subtypes of invasive breast cancer. They differ with regard to presentation, metastatic spread, and epidemiologic features. To elucidate the genetic basis of these differences, we analyzed copy number imbalances that differentiate the histologic subtypes. Experimental Design: High-resolution genomic profiling of 40 invasive breast cancers using matrix-comparative genomic hybridization with an average resolution of 0.5 Mb was conducted on bacterial artificial chromosome microarrays. The data were subjected to classification and unsupervised hierarchical cluster analyses. Expression of candidate genes was analyzed in tumor samples. Results: The highest discriminating power was achieved when combining the aberration patterns of chromosome arms 1q and 16p, which were significantly more often gained in ILC. These regions were further narrowed down to subregions 1q24.2-25.1, 1q25.3-q31.3, and 16p11.2. Located within the candidate gains on 1q are two genes, FMO2 and PTGS2, known to be overexpressed in ILC relative to invasive ductal carcinoma. Assessment of four candidate genes on 16p11.2 by real-time quantitative PCR revealed significant overexpression of FUS and ITGAX in ILC with 16p copy number gain. Unsupervised hierarchical cluster analysis identified three molecular subgroups that are characterized by different aberration patterns, in particular concerning gain of MYC (8q24) and the identified candidate regions on 1q24.2-25.1, 1q25.3-q31.3, and 16p11.2. These genetic subgroups differed with regard to histology, tumor grading, frequency of alterations, and estrogen receptor expression. Conclusions: Molecular profiling using bacterial artificial chromosome arrays identified DNA copy number imbalances on 1q and 16p as significant classifiers of histologic and molecular subgroups.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 55 条
[1]  
Aliferis CF, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P7
[2]   The role of COX-2 inhibition in breast cancer treatment and prevention [J].
Arun, B ;
Goss, P .
SEMINARS IN ONCOLOGY, 2004, 31 (02) :22-29
[3]  
Bijwaard KE, 2001, CLIN CHEM, V47, P195
[4]  
Brenner AJ, 1997, PROG CLIN BIOL RES, V396, P63
[5]   Aromatase and COX-2 expression in human breast cancers [J].
Brodie, AMH ;
Lu, Q ;
Long, BJ ;
Fulton, A ;
Chen, T ;
Macpherson, N ;
DeJong, PC ;
Blankenstein, MA ;
Nortier, JWR ;
Slee, PHTJ ;
van de Ven, J ;
van Gorp, JMHH ;
Elbers, JRJ ;
Schipper, MEI ;
Blijham, GH ;
Thijssen, JH .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5) :41-47
[6]   Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast [J].
Buerger, H ;
Mommers, EC ;
Littmann, R ;
Diallo, R ;
Brinkschmidt, C ;
Poremba, C ;
Dockhorn-Dworniczak, B ;
van Diest, PJ ;
Böcker, W .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (06) :854-859
[7]   Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution [J].
Buerger, H ;
Mommers, EC ;
Littmann, R ;
Simon, R ;
Diallo, R ;
Poremba, C ;
Dockhom-Dworniczak, B ;
van Diest, PJ ;
Boecker, W .
JOURNAL OF PATHOLOGY, 2001, 194 (02) :165-170
[8]   Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays [J].
Callagy, G ;
Pharoah, P ;
Chin, SF ;
Sangan, T ;
Daigo, Y ;
Jackson, L ;
Caldas, C .
JOURNAL OF PATHOLOGY, 2005, 205 (03) :388-396
[9]   E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? [J].
Cleton-Jansen, AM .
BREAST CANCER RESEARCH, 2002, 4 (01) :5-8
[10]   Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast [J].
Droufakou, S ;
Deshmane, V ;
Roylance, R ;
Hanby, A ;
Tomlinson, I ;
Hart, IR .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (03) :404-408